When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
NONOF - Horizon Therapeutics Will Offer Above Average Returns
Novo-Nordisk A/S
Horizon Therapeutics has now reached a growth point that is supportive of long-term success due to multiple eggs in the basket.
The company has 11 FDA approved drugs and 10 phase 2 or 3 clinical trials underway, with revenue growth currently averaging 91% per year over the past 10 years.
While growth is likely to fall in line with peers, I believe this multi-approval stage biotech will offer above-average returns.